Immuron Limited (ASX:IMC)
Australia
· Delayed Price · Currency is AUD 0.0650
+0.0010 (1.56%)
May 23, 2025, 2:59 PM AEST
Immuron Employees
Immuron had 7 employees as of June 30, 2024. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
934.52K AUD
Profits / Employee
-1.05M AUD
Market Cap
15.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 7 | 1 | 16.67% |
| Jun 30, 2023 | 6 | 1 | 20.00% |
| Jun 30, 2022 | 5 | -11 | -68.75% |
| Jun 30, 2014 | 16 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CSL Limited | 32,698 |
| Cochlear | 5,097 |
| Sonic Healthcare | 42,000 |
| Telix Pharmaceuticals | 234 |
| Ramsay Health Care | 90,000 |
| Ansell | 15,000 |
| Regis Healthcare | 11,000 |
| Mesoblast | 73 |
Immuron News
- 6 weeks ago - Immuron (IMRN) Achieves Record Sales Milestone - GuruFocus
- 6 weeks ago - Immuron exceeds AUD$5 million in sales in a fiscal year - Seeking Alpha
- 6 weeks ago - Immuron Travelan® highest sales in history - GlobeNewsWire
- 2 months ago - Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - GlobeNewsWire
- 4 months ago - Immuron Travelan® continued strong sales growth - GlobeNewsWire
- 4 months ago - Immuron Announces New Research Collaboration targeting Antimicrobial Resistance - GlobeNewsWire
- 4 months ago - Immuron Announces Travelan® Clinical Trial Update - GlobeNewsWire
- 6 months ago - Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th - GlobeNewsWire